glutamine has been researched along with fluorouracil in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (15.38) | 18.7374 |
| 1990's | 6 (15.38) | 18.2507 |
| 2000's | 9 (23.08) | 29.6817 |
| 2010's | 15 (38.46) | 24.3611 |
| 2020's | 3 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Coit, R; Magno, M; Woolley, PV | 1 |
| Goh, SH; Léjohn, HB | 1 |
| Rosen, B; Rothman, F; Weigert, MG | 1 |
| Burk, D; Woods, MW | 1 |
| Elia, M; Jebb, SA; Mack, P; Maughan, TS; Mohideen, N; Mort, D; Osborne, RJ; Shelley, MD | 1 |
| Anderson, PM; Skubitz, KM | 1 |
| Fujita, H; Matsui, M; Shirouzu, K; Shirouzu, Y; Yamana, H; Yoshida, S | 1 |
| Sugimura, K; Sukemori, S | 1 |
| Axvig, C; Clemens-Schutjer, D; Ebbert, LP; LaVasseur, BI; Loprinzi, CL; Michalak, JC; Okuno, SH; Pierson, N; Sloan, JA; Swan, D; Tirona, MR; Woodhouse, CO | 1 |
| Buhl, K; Decker-Baumann, C; Dueck, M; Frohmüller, S; Schlag, PM; von Herbay, A | 1 |
| Abbiati, R; Barletta, E; D'Agostino, L; Daniele, B; De Martino, S; De Vivo, R; Gallo, C; Perrone, F; Pignata, S; Tambaro, R | 1 |
| ANDERSON, EP; BROCKMAN, RW | 1 |
| WU, C | 1 |
| Ansari, R; Cheng, L; Helft, P; Juliar, B; Loehrer, P; Pan, CX; Pletcher, W; Seitz, D; Sweeney, C; Vinson, J | 1 |
| Choi, K; Jeon, WK; Kim, JW; Lee, SS; Lim, SY; Oh, SJ; Oh, TY | 1 |
| Chen, PM; Chen, WS; Chiou, TJ; Jiang, JK; Lin, JK; Lin, TC; Liu, JH; Wang, HS; Wang, WS; Yen, CC | 1 |
| Bellaguarda, EA; Brito, GA; Leitão, RF; Lira, AM; Macedo, FD; Ribeiro, RA; Silva, LR; Sousa, RB | 1 |
| Braga-Neto, MB; Brito, GA; Guerrant, RL; Lima, AA; Maciel, AA; Monteiro, MS; Oriá, RB; Warren, CA | 1 |
| Baracos, VE; Dieleman, LA; Field, CJ; Le Roy, S; Sawyer, MB; Xue, H | 1 |
| Kaji, H; Maiguma, T; Makino, K; Teshima, D | 1 |
| Cuezva, JM; Sánchez-Aragó, M | 1 |
| Anderluh, F; Kompan, L; Mlakar Mastnak, D; Možina, B; Oblak, I; Rotovnik Kozjek, N; Soeters, P; Velenik, V; Zadnik, V | 1 |
| Farias, JW; Furtado, FS; Guimarães, SB; Silva Filho, AR; Vasconcelos, PR | 1 |
| Algara López, M; Fernández-Velilla Cepria, E; Foro Arnalot, P; Lacruz Bassols, M; Lozano Galán, J; Membrive Conejo, I; Quera Jordana, J; Reig Castillejo, A; Rodríguez de Dios, N; Sanz Latiesas, J | 1 |
| Geater, A; Laohawiriyakamol, S; Pradutkanchana, J; Puttawibul, P; Raungkhajorn, P; Ruangsin, S; Sangthawan, D; Sunpaweravong, P; Sunpaweravong, S | 1 |
| Fujii, C; Fujino, M; Fukunaga, M; Hachino, Y; Hamaguchi, Y; Imamura, H; Iseki, C; Ishizaka, T; Kamigaki, S; Kawabata, R; Kawase, T; Kimura, Y; Yamamoto, E | 1 |
| Aihara, M; Asakura, M; Furukita, Y; Goto, M; Harada, N; Mawatari, K; Minato, T; Nakaya, Y; Nishino, T; Seike, J; Takechi, H; Takizawa, H; Tangoku, A; Yamai, H; Yamamoto, Y; Yoshida, T; Yuasa, Y | 1 |
| Alhamed, A; Chatterjee, A; Foster, DA; Hosny, C; Mukhopadhyay, S; Saqcena, M | 1 |
| Akagi, Y; Matono, K; Ogata, Y; Shirouzu, K; Tsuda, H; Uchida, S; Ushijima, M | 1 |
| Amsellem, C; Assenat, E; Bachmann, P; Collin, F; Courraud, J; Cristiani, I; de Forges, H; Dechelotte, P; Janiszewski, C; Khemissa, F; Mineur, L; Ramdani, M; Senesse, P | 1 |
| Chen, X; Cheng, J; Huang, G; Liu, C; Liu, X; Peng, Z; Yu, F; Yuan, C | 1 |
| Hong, D; Hong, KM; Kang, JH; Kim, SY; Lee, JS; Lee, SH; Son, J; Song, J | 1 |
| Ferdous, T; Harada, K; Kobayashi, H; Ueyama, Y | 1 |
| Bian, X; Chan, LS; Chen, H; Gou, H; Ji, F; Kang, W; Li, W; Liu, D; Qian, Y; Shirasawa, S; Sung, JJ; Wong, CC; Wu, JL; Xu, J; Yat Luk, ST; Yu, J; Zhou, Q | 1 |
| Al-Taie, A; Koseoglu, A | 1 |
| Almorsy, WA; Arab, HH; Kabel, AM; Khafagy, ES; Naguib, TM; Sabry, NM | 1 |
2 review(s) available for glutamine and fluorouracil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
BIOCHEMISTRY OF CANCER (METABOLIC ASPECTS).
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor; DNA; DNA, Neoplasm; Floxuridine; Fluorouracil; Folic Acid; Glutamine; Leukemia L1210; Mercaptopurine; Methotrexate; Mitomycin; Neoplasms; Neoplasms, Experimental; Pharmacology; Purines; Puromycin; Pyrimidines; Research; RNA; RNA, Neoplasm; Thioguanine; Thiouracil | 1963 |
16 trial(s) available for glutamine and fluorouracil
| Article | Year |
|---|---|
5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Double-Blind Method; Feasibility Studies; Female; Fluorouracil; Gastrointestinal Neoplasms; Glutamine; Humans; Leucovorin; Male; Mouth Mucosa; Pilot Projects; Stomatitis | 1994 |
Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Double-Blind Method; Doxorubicin; Etoposide; Female; Fluorouracil; Glutamine; Humans; Ifosfamide; Male; Neoplasms; Pilot Projects; Placebos; Sarcoma, Kaposi; Stomatitis; Vincristine | 1996 |
Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Membrane Permeability; Cisplatin; Combined Modality Therapy; Dietary Supplements; Esophageal Neoplasms; Female; Fluorouracil; Glutamine; Humans; Indicators and Reagents; Intestinal Mucosa; Intestines; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Phenolsulfonphthalein; Radiation-Sensitizing Agents | 1998 |
Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy.
Topics: Administration, Oral; Administration, Topical; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Glutamine; Humans; Male; Middle Aged; Mouthwashes; Stomatitis | 1999 |
Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Glutamine; Humans; Infusions, Parenteral; Intestinal Mucosa; Leucovorin; Male; Middle Aged; Prospective Studies | 1999 |
Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Colonic Neoplasms; Diarrhea; Double-Blind Method; Female; Fluorouracil; Glutamine; Humans; Intestinal Absorption; Male; Middle Aged; Statistics, Nonparametric | 2001 |
A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Celecoxib; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Diarrhea; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Glutamine; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Pyrazoles; Sulfonamides; Treatment Outcome | 2005 |
The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chromium Radioisotopes; Edetic Acid; Female; Fluorouracil; Glutamine; Humans; Intestinal Absorption; Leucovorin; Male; Middle Aged; Mucositis; Neoplasms; Permeability; Severity of Illness Index; Stomatitis; Treatment Outcome | 2007 |
Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Colorectal Neoplasms; Female; Fluorouracil; Glutamine; Humans; Leucovorin; Male; Middle Aged; Nervous System Diseases; Neuroprotective Agents; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; Treatment Outcome | 2007 |
Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemical Phenomena; Chemoradiotherapy, Adjuvant; Deoxycytidine; Diarrhea; Dietary Supplements; Double-Blind Method; Female; Fluorouracil; Gastrointestinal Tract; Glutamine; Humans; Incidence; Male; Middle Aged; Patient Dropouts; Pilot Projects; Preoperative Period; Rectal Neoplasms; Severity of Illness Index | 2011 |
Oxidative stress parameters in women with breast cancer undergoing neoadjuvant chemotherapy and treated with nutraceutical doses of oral glutamine.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Fluorouracil; Glutamine; Glutathione; Humans; Middle Aged; Neoadjuvant Therapy; Oxidative Stress; Prospective Studies; Statistics, Nonparametric; Thiobarbituric Acid Reactive Substances; Time Factors | 2011 |
Randomized study of antiinflammatory and immune-modulatory effects of enteral immunonutrition during concurrent chemoradiotherapy for esophageal cancer.
Topics: Adult; Aged; Arginine; C-Reactive Protein; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Enteral Nutrition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fatty Acids, Omega-3; Female; Fluorouracil; Glutamine; Humans; Immunity, Cellular; Inflammation Mediators; Interferon-gamma; Interleukin-10; Interleukin-6; Male; Middle Aged; Tumor Necrosis Factor-alpha; Young Adult | 2014 |
Randomized phase II study of 5-fluorouracil hepatic arterial infusion with or without antineoplastons as an adjuvant therapy after hepatectomy for liver metastases from colorectal cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Combinations; Fluorouracil; Glutamine; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome | 2015 |
A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Dietary Supplements; Double-Blind Method; Female; Fluorouracil; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Glutamine; Humans; Male; Middle Aged; Platinum Compounds; Transforming Growth Factor beta | 2016 |
Potential therapeutic effects of different mouthwashes for alleviation and treatment of oral complications of 5-fluorouracil-based chemotherapy in patients with colon cancer.
Topics: Benzydamine; Colonic Neoplasms; Fluorouracil; Glutamine; Humans; Mouthwashes; Pain; Prospective Studies; Quality of Life; Sodium Bicarbonate; Stomatitis; Xerostomia | 2023 |
Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients' Survival: A Randomized Controlled Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Dipeptides; Fluorouracil; Glutamine; Humans; Incidence; Leucovorin; Organoplatinum Compounds; Quality of Life | 2022 |
21 other study(ies) available for glutamine and fluorouracil
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Possibilities for a role of L-glutamine and L-asparagine antagonists in the treatment of gastrointestinal cancer.
Topics: Animals; Asparagine; Azo Compounds; Drug Therapy, Combination; Fluorouracil; Gastrointestinal Neoplasms; Glutamine; Humans; Leukemia L1210; Mice; Tryptophan | 1979 |
Genetical and biochemical evidence that a novel dinucleoside polyphosphate coordinates salvage and de novo nucleotide biosynthetic pathways in mammalian cells.
Topics: Azaserine; Cell Line; Fluorouracil; Genes; Glutamine; Guanosine Triphosphate; Methotrexate; Mutation; Oligonucleotides; Oligoribonucleotides; Ribonucleotides | 1977 |
Miscoding caused by 5-fluorouracil.
Topics: Alkaline Phosphatase; Amino Acids; Base Sequence; Coliphages; Culture Media; Escherichia coli; Fluorouracil; Genetic Code; Glutamine; Mutation; Peptides; Phenotype; Protein Denaturation; Trypsin | 1969 |
Antiglycolytic activities of 5-fluorouracil and related pyrimidines in mouse ascites carcinoma cells with special reference to inorganic phosphate and glucose.
Topics: Adenine; Animals; Arsenic; Carcinoma, Ehrlich Tumor; Carcinoma, Krebs 2; Deoxyuridine; Fluorouracil; Fructose; Glucose; Glutamine; Glycolysis; In Vitro Techniques; Manometry; Mice; Nucleosides; Phenols; Phosphates; Pyrimidines; Pyruvates; Respiration; Succinates; Uracil; Uridine | 1969 |
Extracellular glutamine level reduction enhances 5-fluorouracil cytotoxicity.
Topics: Amino Acids; Animals; Asparagine; Cell Count; Dose-Response Relationship, Drug; Fluorouracil; Glutamine; Humans; Leukemia; Leukemia P388; Methotrexate; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1998 |
GLUTAMINE SYNTHETASE. 3. FACTORS CONTROLLING ITS ACTIVITY IN THE DEVELOPING RAT.
Topics: Amino Acids; Ammonium Compounds; Animals; Animals, Newborn; Azaguanine; Brain; Dactinomycin; Ethionine; Fluorouracil; Glutamate-Ammonia Ligase; Glutamates; Glutamine; Humans; Hydrocortisone; Kidney; Lactates; Ligases; Liver; Male; Nucleosides; Pharmacology; Phenylalanine; Puromycin; Quaternary Ammonium Compounds; Rats; Research; Testis; Thiouracil; Thyroxine | 1964 |
Glutamine and alanyl-glutamine accelerate the recovery from 5-fluorouracil-induced experimental oral mucositis in hamster.
Topics: Animals; Antimetabolites, Antineoplastic; Cricetinae; Dipeptides; Fluorouracil; Glutamine; Glutathione; Male; Mesocricetus; Mouth Mucosa; Neutrophil Infiltration; Peroxidase; Stomatitis; Sulfhydryl Compounds | 2008 |
Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Line; Cell Movement; Cell Proliferation; Dipeptides; Dose-Response Relationship, Drug; Fluorouracil; Glutamine; Intestinal Mucosa; Jejunum; Models, Animal; Rats; Time Factors | 2008 |
Single and combined supplementation of glutamine and n-3 polyunsaturated fatty acids on host tolerance and tumour response to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin (CPT-11)/5-fluorouracil chemotherapy in rats bearing Ward colo
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Camptothecin; Colonic Neoplasms; Combined Modality Therapy; Diarrhea; Dietary Supplements; Fatty Acids, Omega-3; Female; Fluorouracil; Glutamine; Immune Tolerance; Irinotecan; Leukocyte Count; Nutritional Status; Rats; Rats, Inbred F344; Treatment Failure; Xenograft Model Antitumor Assays | 2009 |
Protective effects of amifostine and cyclooxygenase-1 inhibitor against normal human epidermal keratinocyte toxicity induced by methotrexate and 5-fluorouracil.
Topics: Allopurinol; Amifostine; Antimetabolites, Antineoplastic; Calcium; Cell Line; Cell Proliferation; Cell Survival; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Fibroblasts; Fluorouracil; Free Radical Scavengers; Glutamine; Humans; Keratinocytes; Methotrexate; Periodontal Ligament; Protective Agents; Pyrazoles; Reactive Oxygen Species; Stomatitis | 2009 |
The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil.
Topics: Adenosine Triphosphate; Blotting, Western; Cell Death; Colonic Neoplasms; Energy Metabolism; Fluorouracil; Glutamine; HCT116 Cells; Humans; Iodoacetates; Pyruvates; Remission Induction; Signal Transduction | 2011 |
Prevention of acute radiation enteritis: efficacy and tolerance of glutamine.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Diarrhea; Female; Fluorouracil; Glutamine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Pelvic Neoplasms; Prognosis; Prospective Studies; Quality of Life | 2011 |
[Efficacy of AboundTM for hand-foot syndrome caused by capecitabine].
Topics: Aged; Antimetabolites, Antineoplastic; Arginine; Butyrates; Capecitabine; Deoxycytidine; Female; Fluorouracil; Glutamine; Hand-Foot Syndrome; Humans; Hydroxy Acids; Male; Middle Aged; Neoplasms | 2013 |
Glutamine protects the small intestinal mucosa in anticancer drug-induced rat enteritis model.
Topics: Administration, Oral; Amine Oxidase (Copper-Containing); Animals; Antineoplastic Agents; Dietary Fiber; Disease Models, Animal; Enteritis; Fluorouracil; Glutamine; Immunoglobulin A; Intestinal Mucosa; Jejunum; Male; Oligosaccharides; Rats; Rats, Sprague-Dawley | 2014 |
Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Capecitabine; Cell Cycle Checkpoints; Cell Line, Tumor; Citric Acid Cycle; Cytotoxins; Deoxycytidine; Fluorouracil; Glutamine; Humans; Mutation; Neoplasms; Paclitaxel; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins | 2015 |
Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.
Topics: Aged; Animals; Antimetabolites, Antineoplastic; Cell Survival; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Expression; Glutamine; HT29 Cells; Humans; Inhibitory Concentration 50; Kaplan-Meier Estimate; Male; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitochondrial Proteins; Multivariate Analysis; Neoplasm Transplantation; Prognosis; Proportional Hazards Models; Sirtuins | 2016 |
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
Topics: A549 Cells; Adenosine Triphosphate; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Death; Cell Proliferation; Cell Survival; Cytosol; Drug Synergism; Fluorouracil; Gene Knockdown Techniques; Glutamic Acid; Glutaminase; Glutamine; Lung Neoplasms; Malates; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; NAD; Oxidation-Reduction; Sulfides; Thiadiazoles; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2016 |
Elemental Diet Accelerates the Recovery From Oral Mucositis and Dermatitis Induced by 5-Fluorouracil Through the Induction of Fibroblast Growth Factor 2.
Topics: Animals; Dermatitis; Female; Fibroblast Growth Factor 2; Fluorouracil; Food, Formulated; Glutamine; Japan; Male; Mesocricetus; Mice; Mice, Nude; Skin; Stomatitis | 2018 |
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Topics: Animals; Colon; Colorectal Neoplasms; DNA Demethylation; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glutamine; Hong Kong; Humans; Intestinal Mucosa; Kaplan-Meier Estimate; Ketoglutaric Acids; Male; Mice, Knockout; Mitochondrial Membrane Transport Proteins; Neoplastic Stem Cells; Proto-Oncogene Proteins p21(ras); Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2020 |